Home > > > Report Detail

Global Bronchiectasis Therapeutic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 30-Nov-2022
No. of pages: 96
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Bronchiectasis Therapeutic companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Bronchiectasis Therapeutic market. Further, it explains the major drivers and regional dynamics of the global Bronchiectasis Therapeutic market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- GlaxoSmithKline

- Alitair Pharmaceuticals Inc.

- Bayer AG

- Chiesi Farmaceutici SpA

- Grifols SA

- Insmed Inc

- Kamada Ltd

- Polyphor Ltd

- Recipharm AB

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Bronchiectasis Therapeutic Segment by Type

- Antibiotics

- Expectorants

- Others

Bronchiectasis Therapeutic Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Bronchiectasis Therapeutic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Bronchiectasis Therapeutic market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Bronchiectasis Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Bronchiectasis Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bronchiectasis Therapeutic revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Bronchiectasis Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Bronchiectasis Therapeutic revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including GlaxoSmithKline, Alitair Pharmaceuticals Inc., Bayer AG, Chiesi Farmaceutici SpA, Grifols SA, Insmed Inc, Kamada Ltd, Polyphor Ltd and Recipharm AB, etc.

Global Bronchiectasis Therapeutic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchiectasis Therapeutic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Antibiotics
1.2.3 Expectorants
1.2.4 Others
1.3 Market by Application
1.3.1 Global Bronchiectasis Therapeutic Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Bronchiectasis Therapeutic Market Size (2017-2028)
2.2 Bronchiectasis Therapeutic Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Bronchiectasis Therapeutic Market Size by Region (2017-2022)
2.4 Global Bronchiectasis Therapeutic Market Size Forecast by Region (2023-2028)
2.5 Global Top Bronchiectasis Therapeutic Countries Ranking by Market Size
3 Bronchiectasis Therapeutic Competitive by Company
3.1 Global Bronchiectasis Therapeutic Revenue by Players
3.1.1 Global Bronchiectasis Therapeutic Revenue by Players (2017-2022)
3.1.2 Global Bronchiectasis Therapeutic Market Share by Players (2017-2022)
3.2 Global Bronchiectasis Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Bronchiectasis Therapeutic Revenue
3.4 Global Bronchiectasis Therapeutic Market Concentration Ratio
3.4.1 Global Bronchiectasis Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Therapeutic Revenue in 2021
3.5 Global Bronchiectasis Therapeutic Key Players Head office and Area Served
3.6 Key Players Bronchiectasis Therapeutic Product Solution and Service
3.7 Date of Enter into Bronchiectasis Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Bronchiectasis Therapeutic Breakdown Data by Type
4.1 Global Bronchiectasis Therapeutic Historic Revenue by Type (2017-2022)
4.2 Global Bronchiectasis Therapeutic Forecasted Revenue by Type (2023-2028)
5 Global Bronchiectasis Therapeutic Breakdown Data by Application
5.1 Global Bronchiectasis Therapeutic Historic Market Size by Application (2017-2022)
5.2 Global Bronchiectasis Therapeutic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Bronchiectasis Therapeutic Revenue by Company (2020-2022)
6.2 North America Bronchiectasis Therapeutic Revenue by Type (2017-2028)
6.3 North America Bronchiectasis Therapeutic Revenue by Application (2017-2028)
6.4 North America Bronchiectasis Therapeutic Revenue by Country (2017-2028)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Bronchiectasis Therapeutic Revenue by Company (2020-2022)
7.2 Europe Bronchiectasis Therapeutic Revenue by Type (2017-2028)
7.3 Europe Bronchiectasis Therapeutic Revenue by Application (2017-2028)
7.4 Europe Bronchiectasis Therapeutic Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Bronchiectasis Therapeutic Revenue by Company (2020-2022)
8.2 Asia Pacific Bronchiectasis Therapeutic Revenue by Type (2017-2028)
8.3 Asia Pacific Bronchiectasis Therapeutic Revenue by Application (2017-2028)
8.4 Asia Pacific Bronchiectasis Therapeutic Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Bronchiectasis Therapeutic Revenue by Company (2020-2022)
9.2 Latin America Bronchiectasis Therapeutic Revenue by Type (2017-2028)
9.3 Latin America Bronchiectasis Therapeutic Revenue by Application (2017-2028)
9.4 Latin America Bronchiectasis Therapeutic Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bronchiectasis Therapeutic Revenue by Company (2020-2022)
10.2 Middle East and Africa Bronchiectasis Therapeutic Revenue by Type (2017-2028)
10.3 Middle East and Africa Bronchiectasis Therapeutic Revenue by Application (2017-2028)
10.4 Middle East and Africa Bronchiectasis Therapeutic Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Bronchiectasis Therapeutic Products and Services
11.1.4 GlaxoSmithKline Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022)
11.1.5 GlaxoSmithKline Bronchiectasis Therapeutic SWOT Analysis
11.1.6 GlaxoSmithKline Recent Developments
11.2 Alitair Pharmaceuticals Inc.
11.2.1 Alitair Pharmaceuticals Inc. Company Details
11.2.2 Alitair Pharmaceuticals Inc. Business Overview
11.2.3 Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Products and Services
11.2.4 Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022)
11.2.5 Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic SWOT Analysis
11.2.6 Alitair Pharmaceuticals Inc. Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Bronchiectasis Therapeutic Products and Services
11.3.4 Bayer AG Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022)
11.3.5 Bayer AG Bronchiectasis Therapeutic SWOT Analysis
11.3.6 Bayer AG Recent Developments
11.4 Chiesi Farmaceutici SpA
11.4.1 Chiesi Farmaceutici SpA Company Details
11.4.2 Chiesi Farmaceutici SpA Business Overview
11.4.3 Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Products and Services
11.4.4 Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022)
11.4.5 Chiesi Farmaceutici SpA Bronchiectasis Therapeutic SWOT Analysis
11.4.6 Chiesi Farmaceutici SpA Recent Developments
11.5 Grifols SA
11.5.1 Grifols SA Company Details
11.5.2 Grifols SA Business Overview
11.5.3 Grifols SA Bronchiectasis Therapeutic Products and Services
11.5.4 Grifols SA Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022)
11.5.5 Grifols SA Bronchiectasis Therapeutic SWOT Analysis
11.5.6 Grifols SA Recent Developments
11.6 Insmed Inc
11.6.1 Insmed Inc Company Details
11.6.2 Insmed Inc Business Overview
11.6.3 Insmed Inc Bronchiectasis Therapeutic Products and Services
11.6.4 Insmed Inc Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022)
11.6.5 Insmed Inc Bronchiectasis Therapeutic SWOT Analysis
11.6.6 Insmed Inc Recent Developments
11.7 Kamada Ltd
11.7.1 Kamada Ltd Company Details
11.7.2 Kamada Ltd Business Overview
11.7.3 Kamada Ltd Bronchiectasis Therapeutic Products and Services
11.7.4 Kamada Ltd Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022)
11.7.5 Kamada Ltd Bronchiectasis Therapeutic SWOT Analysis
11.7.6 Kamada Ltd Recent Developments
11.8 Polyphor Ltd
11.8.1 Polyphor Ltd Company Details
11.8.2 Polyphor Ltd Business Overview
11.8.3 Polyphor Ltd Bronchiectasis Therapeutic Products and Services
11.8.4 Polyphor Ltd Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022)
11.8.5 Polyphor Ltd Bronchiectasis Therapeutic SWOT Analysis
11.8.6 Polyphor Ltd Recent Developments
11.9 Recipharm AB
11.9.1 Recipharm AB Company Details
11.9.2 Recipharm AB Business Overview
11.9.3 Recipharm AB Bronchiectasis Therapeutic Products and Services
11.9.4 Recipharm AB Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022)
11.9.5 Recipharm AB Bronchiectasis Therapeutic SWOT Analysis
11.9.6 Recipharm AB Recent Developments
12 Bronchiectasis Therapeutic Market Dynamics
12.1 Bronchiectasis Therapeutic Market Trends
12.2 Bronchiectasis Therapeutic Market Drivers
12.3 Bronchiectasis Therapeutic Market Challenges
12.4 Bronchiectasis Therapeutic Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Bronchiectasis Therapeutic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Antibiotics
Table 3. Key Players of Expectorants
Table 4. Key Players of Others
Table 5. Global Bronchiectasis Therapeutic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Bronchiectasis Therapeutic Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Bronchiectasis Therapeutic Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Bronchiectasis Therapeutic Revenue Market Share by Region (2017-2022)
Table 9. Global Bronchiectasis Therapeutic Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Bronchiectasis Therapeutic Market Share by Players (2017-2022)
Table 11. Global Top Bronchiectasis Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Therapeutic as of 2021)
Table 12. Ranking of Global Top Bronchiectasis Therapeutic Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Bronchiectasis Therapeutic Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Bronchiectasis Therapeutic Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Bronchiectasis Therapeutic Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Bronchiectasis Therapeutic Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Bronchiectasis Therapeutic Revenue Market Share by Type (2017-2022)
Table 20. Global Bronchiectasis Therapeutic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Bronchiectasis Therapeutic Revenue Market Share by Type (2023-2028)
Table 22. Global Bronchiectasis Therapeutic Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Bronchiectasis Therapeutic Revenue Market Share by Application (2017-2022)
Table 24. Global Bronchiectasis Therapeutic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Bronchiectasis Therapeutic Revenue Market Share by Application (2023-2028)
Table 26. North America Bronchiectasis Therapeutic Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Bronchiectasis Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Bronchiectasis Therapeutic Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Bronchiectasis Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Bronchiectasis Therapeutic Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Bronchiectasis Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Bronchiectasis Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Bronchiectasis Therapeutic Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Bronchiectasis Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Bronchiectasis Therapeutic Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Bronchiectasis Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Bronchiectasis Therapeutic Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Bronchiectasis Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Bronchiectasis Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Bronchiectasis Therapeutic Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Bronchiectasis Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Bronchiectasis Therapeutic Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Bronchiectasis Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Bronchiectasis Therapeutic Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Bronchiectasis Therapeutic Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Bronchiectasis Therapeutic Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Bronchiectasis Therapeutic Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Bronchiectasis Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Bronchiectasis Therapeutic Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Bronchiectasis Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Bronchiectasis Therapeutic Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Bronchiectasis Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Bronchiectasis Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Bronchiectasis Therapeutic Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Bronchiectasis Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Bronchiectasis Therapeutic Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Bronchiectasis Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Bronchiectasis Therapeutic Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Bronchiectasis Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Bronchiectasis Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Bronchiectasis Therapeutic Product and Services
Table 64. GlaxoSmithKline Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022) & (US$ Million)
Table 65. GlaxoSmithKline Bronchiectasis Therapeutic SWOT Analysis
Table 66. GlaxoSmithKline Recent Developments
Table 67. Alitair Pharmaceuticals Inc. Company Details
Table 68. Alitair Pharmaceuticals Inc. Business Overview
Table 69. Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Product and Services
Table 70. Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022) & (US$ Million)
Table 71. Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic SWOT Analysis
Table 72. Alitair Pharmaceuticals Inc. Recent Developments
Table 73. Bayer AG Company Details
Table 74. Bayer AG Business Overview
Table 75. Bayer AG Bronchiectasis Therapeutic Product and Services
Table 76. Bayer AG Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022) & (US$ Million)
Table 77. Bayer AG Bronchiectasis Therapeutic SWOT Analysis
Table 78. Bayer AG Recent Developments
Table 79. Chiesi Farmaceutici SpA Company Details
Table 80. Chiesi Farmaceutici SpA Business Overview
Table 81. Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Product and Services
Table 82. Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022) & (US$ Million)
Table 83. Chiesi Farmaceutici SpA Bronchiectasis Therapeutic SWOT Analysis
Table 84. Chiesi Farmaceutici SpA Recent Developments
Table 85. Grifols SA Company Details
Table 86. Grifols SA Business Overview
Table 87. Grifols SA Bronchiectasis Therapeutic Product and Services
Table 88. Grifols SA Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022) & (US$ Million)
Table 89. Grifols SA Bronchiectasis Therapeutic SWOT Analysis
Table 90. Grifols SA Recent Developments
Table 91. Insmed Inc Company Details
Table 92. Insmed Inc Business Overview
Table 93. Insmed Inc Bronchiectasis Therapeutic Product and Services
Table 94. Insmed Inc Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022) & (US$ Million)
Table 95. Insmed Inc Bronchiectasis Therapeutic SWOT Analysis
Table 96. Insmed Inc Recent Developments
Table 97. Kamada Ltd Company Details
Table 98. Kamada Ltd Business Overview
Table 99. Kamada Ltd Bronchiectasis Therapeutic Product and Services
Table 100. Kamada Ltd Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022) & (US$ Million)
Table 101. Kamada Ltd Bronchiectasis Therapeutic SWOT Analysis
Table 102. Kamada Ltd Recent Developments
Table 103. Polyphor Ltd Company Details
Table 104. Polyphor Ltd Business Overview
Table 105. Polyphor Ltd Bronchiectasis Therapeutic Product and Services
Table 106. Polyphor Ltd Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022) & (US$ Million)
Table 107. Polyphor Ltd Bronchiectasis Therapeutic SWOT Analysis
Table 108. Polyphor Ltd Recent Developments
Table 109. Recipharm AB Company Details
Table 110. Recipharm AB Business Overview
Table 111. Recipharm AB Bronchiectasis Therapeutic Product and Services
Table 112. Recipharm AB Bronchiectasis Therapeutic Revenue in Bronchiectasis Therapeutic Business (2017-2022) & (US$ Million)
Table 113. Recipharm AB Bronchiectasis Therapeutic SWOT Analysis
Table 114. Recipharm AB Recent Developments
Table 115. Bronchiectasis Therapeutic Market Trends
Table 116. Bronchiectasis Therapeutic Market Drivers
Table 117. Bronchiectasis Therapeutic Market Challenges
Table 118. Bronchiectasis Therapeutic Market Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchiectasis Therapeutic Sales Market Share by Type: 2021 VS 2028
Figure 2. Antibiotics Features
Figure 3. Expectorants Features
Figure 4. Others Features
Figure 5. Global Bronchiectasis Therapeutic Sales Market Share by Application: 2021 VS 2028
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Bronchiectasis Therapeutic Report Years Considered
Figure 10. Global Bronchiectasis Therapeutic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Bronchiectasis Therapeutic Market Size 2017-2028 (US$ Million)
Figure 12. Global Bronchiectasis Therapeutic Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Bronchiectasis Therapeutic Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Bronchiectasis Therapeutic Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Bronchiectasis Therapeutic Market Share by Players in 2021
Figure 16. Global Top Bronchiectasis Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Therapeutic as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Bronchiectasis Therapeutic Revenue in 2021
Figure 18. North America Bronchiectasis Therapeutic Revenue Market Share by Company in 2021
Figure 19. North America Bronchiectasis Therapeutic Revenue Market Share by Type (2017-2028)
Figure 20. North America Bronchiectasis Therapeutic Revenue Market Share by Application (2017-2028)
Figure 21. North America Bronchiectasis Therapeutic Revenue Share by Country (2017-2028)
Figure 22. United States Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Bronchiectasis Therapeutic Revenue Market Share by Company in 2021
Figure 25. Europe Bronchiectasis Therapeutic Revenue Market Share by Type (2017-2028)
Figure 26. Europe Bronchiectasis Therapeutic Revenue Market Share by Application (2017-2028)
Figure 27. Europe Bronchiectasis Therapeutic Revenue Share by Country (2017-2028)
Figure 28. Germany Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 29. France Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Bronchiectasis Therapeutic Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Bronchiectasis Therapeutic Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Bronchiectasis Therapeutic Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Bronchiectasis Therapeutic Revenue Share by Region (2017-2028)
Figure 37. China Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 40. India Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 42. China Taiwan Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 46. Latin America Bronchiectasis Therapeutic Revenue Market Share by Company in 2021
Figure 47. Latin America Bronchiectasis Therapeutic Revenue Market Share by Type (2017-2028)
Figure 48. Latin America Bronchiectasis Therapeutic Revenue Market Share by Application (2017-2028)
Figure 49. Latin America Bronchiectasis Therapeutic Revenue Share by Country (2017-2028)
Figure 50. Mexico Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 51. Brazil Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 52. Argentina Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Bronchiectasis Therapeutic Revenue Market Share by Company in 2021
Figure 54. Middle East and Africa Bronchiectasis Therapeutic Revenue Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Bronchiectasis Therapeutic Revenue Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Bronchiectasis Therapeutic Revenue Share by Country (2017-2028)
Figure 57. Turkey Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 59. UAE Bronchiectasis Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Bronchiectasis Therapeutic Business (2017-2022)
Figure 61. Alitair Pharmaceuticals Inc. Revenue Growth Rate in Bronchiectasis Therapeutic Business (2017-2022)
Figure 62. Bayer AG Revenue Growth Rate in Bronchiectasis Therapeutic Business (2017-2022)
Figure 63. Chiesi Farmaceutici SpA Revenue Growth Rate in Bronchiectasis Therapeutic Business (2017-2022)
Figure 64. Grifols SA Revenue Growth Rate in Bronchiectasis Therapeutic Business (2017-2022)
Figure 65. Insmed Inc Revenue Growth Rate in Bronchiectasis Therapeutic Business (2017-2022)
Figure 66. Kamada Ltd Revenue Growth Rate in Bronchiectasis Therapeutic Business (2017-2022)
Figure 67. Polyphor Ltd Revenue Growth Rate in Bronchiectasis Therapeutic Business (2017-2022)
Figure 68. Recipharm AB Revenue Growth Rate in Bronchiectasis Therapeutic Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global PACS and EMR Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 86
    A picture archiving and communication system (PACS) is a medical imaging technology which provides economical storage and convenient access to images from multiple modalities (source machine types). Electronic images and reports are transmitted digitally via PACS; this eliminates the need to manually file, retrieve, or transport film jackets, the folders used to store and protect X-ray film. Highlights The global PACS and EMR market was valued at US$ million in 2022 and is ......
  • Global Orthopedic Braces & Support Devices Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 118
    Orthopedic braces are medical devices designed to address musculoskeletal issues; they are used to properly align, correct the position, support, stabilize, and protect certain parts of the body (particularly the muscles, joints, and bones) as they heal from injury or trauma. These medical devices are often prescribed for the patient to wear during the process of recovery and rehabilitation. Highlights The global Orthopedic Braces & Support Devices market was valued at US$ ......
  • Global Orthopedic Bone Graft Substitutes Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 90
    Bone substitutes can be broadly categorized into bone grafts Highlights The global Orthopedic Bone Graft Substitutes market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Orthopedic Bone Graft Substitutes is estimated to increase from $ millio......
  • Global Optical Biometry Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 100
    Optical Biometry also called as partial coherence interferometry (PCI) is an essential method used by ophthalmologist in clinical practice for accurate measurement of the anatomical characteristics of the eye. Highlights The global Optical Biometry market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered whi......
  • Global Intravascular Ultrasound Devices Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 89
    Intravascular ultrasound (IVUS), also known as endovascular ultrasound or intravascular echocardiography, is an imaging technique that uses a transducer or probe to generate sound waves and produce pictures of the insides of blood vessels. Highlights The global Intravascular Ultrasound Devices market was valued at US$ 372 million in 2022 and is anticipated to reach US$ 526.2 million by 2029, witnessing a CAGR of 5.0% during the forecast period 2023-2029. The influence of CO......
  • Global Contraceptive Device Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 94
    Contraceptive Device is a small, often T-shaped birth control device that is inserted into a woman's uterus to prevent pregnancy. Highlights The global Contraceptive Device market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Contraceptive De......
  • Global Standalone Ophthalmic Ultrasound Systems Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 95
    Ultrasound of the eye is not an examination that most sonographers are commonly asked to perform Highlights The global Standalone Ophthalmic Ultrasound Systems market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Standalone Ophthalmic Ultraso......
  • Global Portable Ophthalmic Ultrasound Systems Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 93
    Ultrasound of the eye is not an examination that most sonographers are commonly asked to perform Highlights The global Portable Ophthalmic Ultrasound Systems market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Portable Ophthalmic Ultrasound ......
  • Global Human Endotracheal Tubes Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 104
    Tracheal tubes are frequently used for airway management in the settings of general anesthesia, critical care, mechanical ventilation and emergency medicine. Highlights The global Human Endotracheal Tubes market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North Amer......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sal[email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs